(Q86248331)
Statements
A Multicenter Open-Label Continuation Study in Moderate to Severe Chronic Plaque Psoriasis Subjects Who Completed a Preceding Psoriasis Clinical Study With Adalimumab (English)
0 references
May 2004
0 references
October 2009
0 references
1,469
0 references
18 year
0 references